Submission ID Name Format Submitter Submitted Modified Sort Ascending Certification
DDMODEL00000297 Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women Original code Joel Tarning 2019/02/05 2019/02/15 uncertified model
DDMODEL00000294 Executable_Paracetamol_Zebrafish_345dpf Original code Rob Christiaan van Wijk 2018/08/27 2019/01/04 uncertified model
DDMODEL00000295 Executable_CMS_colistin_PK_CRRT Original code Thierry Buclin 2018/11/13 2018/11/13 uncertified model
DDMODEL00000233 Zierhut_2008_Population PKPD model for Fc-osteoprotegerin in healthy postmenopausal women PharmML 0.8.x Kyle Baron 2016/11/18 2018/07/13 uncertified model
DDMODEL00000290 Executable_simulated_CPathAD Original code Daniela Conrado 2018/05/29 2018/05/30 uncertified model
DDMODEL00000285 Executable_Laouenant_2015_CPTPSP_hb_RBV Original code Julie Bertrand 2018/05/04 2018/05/16 uncertified model
DDMODEL00000284 Bajaj_2017_PK_Nivolumab Original code Andre Jackson 2018/03/26 2018/04/04 uncertified model
DDMODEL00000280 Pharmacokinetics of rifampin in tuberculosis patients Original code Justin Wilkins 2018/02/13 2018/02/13 uncertified model
DDMODEL00000281 PopPK model for lidocaine and its metabolites after long-term use of plasters in post-herpetic neuralgia patients Original code Joachim Grevel 2018/02/13 2018/02/13 uncertified model
DDMODEL00000274 Terranova_2017_oncology_TGI PharmML 0.8.x Elena Maria Tosca 2017/12/21 2017/12/22 uncertified model
DDMODEL00000273 Kovalenko_2016 PK model for dupilumab in atopic dermatitis patients and normals Original code Andre Jackson 2017/12/21 2017/12/21 uncertified model
DDMODEL00000271 Paracetamol and metabolite PK in newborns Original code Elke Krekels 2017/12/21 2017/12/21 uncertified model
DDMODEL00000268 Translational PKPD model on prolactin response following dopamine inhibition- human prediction and validation Original code Liesbeth de Lange 2017/12/13 2017/12/17 uncertified model
DDMODEL00000269 Morphine PK in paediatric population using bodyweight-dependent exponent (BDE) model Original code Elke Krekels 2017/12/14 2017/12/14 uncertified model
DDMODEL00000267 Paracetamol PK in pregnant and non-pregnant women Original code Elke Krekels 2017/12/13 2017/12/14 uncertified model
DDMODEL00000259 The MTP-GPDI model for pre-clinical exposure response and PD interaction identification Original code Oskar Clewe 2017/10/18 2017/11/15 uncertified model
DDMODEL00000110 Magni_2000_diabetes_C-peptide PharmML 0.8.x Paolo Magni 2015/12/11 2017/11/08 uncertified model
DDMODEL00000111 Magni_2004_diabetes_IVGTT PharmML 0.8.x Paolo Magni 2015/12/11 2017/11/08 uncertified model
DDMODEL00000262 Sahota_2015_CPHPC_TMDD_model Original code Alienor Berges 2017/10/25 2017/10/25 uncertified model
DDMODEL00000261 Wilbaux_2015_KPD_CTC.count_PSA Original code Melanie Wilbaux 2017/10/22 2017/10/22 uncertified model
DDMODEL00000256 Phenobarbital PK term and preterm newborns Original code Catherijne Knibbe 2017/10/09 2017/10/09 uncertified model
DDMODEL00000247 Morphine PD in newborns on mechanical ventillation using item response theory (IRT) Original code Catherijne Knibbe 2017/09/07 2017/10/09 uncertified model
DDMODEL00000249 Midazolam PK in critically ill pediatric patients Original code Catherijne Knibbe 2017/09/18 2017/10/09 uncertified model
DDMODEL00000250 Midazolam PK in obese adults and adolescents Original code Catherijne Knibbe 2017/09/18 2017/10/09 uncertified model
DDMODEL00000248 Morphine PK in children younger than three years Original code Catherijne Knibbe 2017/09/08 2017/10/09 uncertified model
DDMODEL00000245 Population Pharmacokinetic Modelling and Estimation of Dosing Strategy for NXY-059, a Nitrone Being Developed for Stroke Original code Agneta Ekholm 2017/08/23 2017/08/24 uncertified model
DDMODEL00000244 Non-linear saturable pharmacokinetic model for high dose rifampicin in tuberculosis patients Original code Robin Svensson 2017/08/11 2017/08/11 uncertified model
DDMODEL00000243 Time to event modelling of competing risks Original code Joachim Grevel 2017/07/12 2017/07/19 uncertified model
DDMODEL00000227 Glucose kinetics in humans: a unique model for different tests PharmML 0.8.x Roberto Bizzotto 2016/10/14 2017/06/30 uncertified model
DDMODEL00000239 Daily and aggregated seizure counts model for scaling from adults to children in epilepsy Original code Rik Schoemaker 2017/05/03 2017/05/15 uncertified model
DDMODEL00000240 The Multistate Tuberculosis Pharmacometric model Original code Oskar Clewe 2017/05/10 2017/05/10 uncertified model
DDMODEL00000237 Zurlinden_2016_Population_PBPK_model_for_acetaminophen Original code Nan-Hung Hsieh 2017/03/27 2017/03/29 uncertified model
DDMODEL00000238 Population PK model for gentamicin Original code Eva Germovsek 2017/03/28 2017/03/28 uncertified model
DDMODEL00000229 A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000230 A pharmacokinetic model for interleukin-21 therapy validated prospectively in murine experiments in melanoma PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000038 PKPD_Tcell_mAb_multiplesclerosis Original code Anne-Gaelle Dosne 2015/11/30 2016/10/31 uncertified model
DDMODEL00000059 PK model of factor VIII in haemophilia A patients Original code João Abrantes 2015/11/30 2016/10/27 uncertified model
DDMODEL00000192 Lestini_2015_PKPD_Oncology Original code Giulia Lestini 2016/05/23 2016/10/27 uncertified model
DDMODEL00000231 PK/PD model of sunitinib in non-small cell lung cancer patients PharmML Moran Optimata 2016/10/27 2016/10/27 uncertified model
DDMODEL00000033 Magnetic Marker Monitoring GI Transit Model Original code Sven van Dijkman 2015/11/30 2016/10/26 uncertified model
DDMODEL00000125 ACTH_Cortisol_Circadian_Rhythm Original code Mats Karlsson 2015/12/13 2016/10/21 uncertified model
DDMODEL00000073 OGTT Integrated Glucose-Insulin (IGI) Model Original code Siti Sheikh Ghadzi 2015/12/03 2016/10/19 uncertified model
DDMODEL00000228 Alskär 2015 Gastric emptying and glucose absorption model Original code Oskar Alskär 2016/10/17 2016/10/17 uncertified model
DDMODEL00000066 Ueckert 2016 ADAS-cog IRT model Original code Sebastian Ueckert 2015/12/01 2016/10/17 uncertified model
DDMODEL00000134 Tsukamoto 2001 PBPK/PD Model for Capecitabine Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000135 Tate 2016 Metastatic Breast Cancer Overall Survival Model Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000137 Tate 2016 Metastatic Breast Cancer Tumour Growth Model for Paclitaxel/Gemcitabine Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000136 Tate 2016 Metastatic Breast Cancer Tumour Growth Model for Docetaxel Combinations Original code Sonya Tate 2016/01/07 2016/10/16 uncertified model
DDMODEL00000069 Savic_transit_abs_glibenclamide_pk_original Original code Gustaf Wellhagen 2015/12/03 2016/10/14 uncertified model
DDMODEL00000115 Russu_2009_dose_escalation_power PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
Showing 1 to 50 of 134 models
First Previous 1 2 3 Next Last